欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/1591/004
药品名称
Alava 320 mg
活性成分
valsartan 320.0 mg
剂型
Film-coated tablet
上市许可持有人
Medical Valley Invest AB Brädgardsvägen 28 23632 Höllviken Sweden
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Luxembourg (LU)
Ireland (IE)
Portugal (PT)
Poland (PL)
Vamadrid
Latvia (LV)
Estonia (EE)
Vamadrid
Hungary (HU)
VAMADRID 320 mg filmtabletta
Bulgaria (BG)
Vamadrid
许可日期
2009/12/03
最近更新日期
2023/11/30
药物ATC编码
A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
Valsartan Xiromed_LF_Valsa_CC_NL_H_1591_001_004_IB_0020_EoP_2022_03_03_cl
Date of last change:2022/06/02
Final SPC
|
Valsartan Xiromed_SPC_Valsa_CC_NL_H_1591_001_004_IB_0020_cl_SPC_Valsa_CC_NL_H_1591_001_004_IB_0020_EoP_2022_03_03_clean
Date of last change:2022/06/02
Final Labelling
|
common-outer- vamadrid
Date of last change:2018/05/02
Final Labelling
|
common-spc-vamadrid
Date of last change:2018/05/02
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase